These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 18804506

  • 1. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
    Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, McGettigan JP.
    Vaccine; 2008 Nov 25; 26(50):6405-14. PubMed ID: 18804506
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a single-cycle rabies virus-based vaccine vector.
    Gomme EA, Faul EJ, Flomenberg P, McGettigan JP, Schnell MJ.
    J Virol; 2010 Mar 25; 84(6):2820-31. PubMed ID: 20053743
    [Abstract] [Full Text] [Related]

  • 3. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
    Li J, Faber M, Papaneri A, Faber ML, McGettigan JP, Schnell MJ, Dietzschold B.
    Virology; 2010 Mar 25; 356(1-2):147-54. PubMed ID: 16938327
    [Abstract] [Full Text] [Related]

  • 4. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
    Wang X, Feng N, Ge J, Shuai L, Peng L, Gao Y, Yang S, Xia X, Bu Z.
    Vaccine; 2012 Jul 20; 30(34):5067-72. PubMed ID: 22698451
    [Abstract] [Full Text] [Related]

  • 5. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.
    Foley HD, McGettigan JP, Siler CA, Dietzschold B, Schnell MJ.
    Proc Natl Acad Sci U S A; 2000 Dec 19; 97(26):14680-5. PubMed ID: 11114165
    [Abstract] [Full Text] [Related]

  • 6. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.
    Ge J, Wang X, Tao L, Wen Z, Feng N, Yang S, Xia X, Yang C, Chen H, Bu Z.
    J Virol; 2011 Aug 19; 85(16):8241-52. PubMed ID: 21632762
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice.
    Faber M, Bette M, Preuss MA, Pulmanausahakul R, Rehnelt J, Schnell MJ, Dietzschold B, Weihe E.
    J Virol; 2005 Dec 19; 79(24):15405-16. PubMed ID: 16306612
    [Abstract] [Full Text] [Related]

  • 8. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
    Giel-Moloney M, Rumyantsev AA, David F, Figueiredo M, Feilmeier B, Mebatsion T, Parrington M, Kleanthous H, Pugachev KV.
    Vaccine; 2017 Dec 14; 35(49 Pt B):6898-6904. PubMed ID: 28899628
    [Abstract] [Full Text] [Related]

  • 9. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK, Sharma S, Walunj SS, Patil AA, Rai A, Saini M.
    Acta Virol; 2006 Dec 14; 50(2):87-92. PubMed ID: 16808325
    [Abstract] [Full Text] [Related]

  • 10. Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model.
    Wu Q, Yu F, Xu J, Li Y, Chen H, Xiao S, Fu ZF, Fang L.
    Vet Microbiol; 2014 Jun 25; 171(1-2):93-101. PubMed ID: 24793501
    [Abstract] [Full Text] [Related]

  • 11. Parainfluenza virus 5 expressing the G protein of rabies virus protects mice after rabies virus infection.
    Huang Y, Chen Z, Huang J, Fu Z, He B.
    J Virol; 2015 Mar 25; 89(6):3427-9. PubMed ID: 25552723
    [Abstract] [Full Text] [Related]

  • 12. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L, Wang X, Wen Z, Ge J, Wang J, Zhao D, Bu Z.
    Antiviral Res; 2017 Oct 25; 146():36-44. PubMed ID: 28822816
    [Abstract] [Full Text] [Related]

  • 13. A single dose of recombinant adenoviral vector rabies vaccine expressing two copies of glycoprotein protects mice from lethal virus challenge.
    Li Q, He H, Zhou Y, Wang J, Chen H, Liu H.
    J Infect Dev Ctries; 2024 Aug 31; 18(8):1281-1290. PubMed ID: 39288397
    [Abstract] [Full Text] [Related]

  • 14. An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice.
    Xue XH, Zheng XX, Wang HL, Ma JZ, Li L, Gai WW, Wang TC, Yang ST, Xia XZ.
    Virus Genes; 2014 Jun 31; 48(3):411-20. PubMed ID: 24535572
    [Abstract] [Full Text] [Related]

  • 15. Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors.
    Astray RM, Ventini DC, Boldorini VL, Silva FG, Rocca MP, Pereira CA.
    Vaccine; 2014 May 19; 32(24):2829-32. PubMed ID: 24598721
    [Abstract] [Full Text] [Related]

  • 16. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
    Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC.
    Virology; 1994 Feb 15; 199(1):132-40. PubMed ID: 8116236
    [Abstract] [Full Text] [Related]

  • 17. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response.
    Rath A, Choudhury S, Batra D, Kapre SV, Rupprecht CE, Gupta SK.
    Virus Res; 2005 Nov 15; 113(2):143-52. PubMed ID: 15978691
    [Abstract] [Full Text] [Related]

  • 18. Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57.
    Duan Y, Gu T, Zhang X, Jiang C, Yuan R, Li Z, Wang D, Chen X, Wu C, Chen Y, Wu Y, Kong W.
    Mol Immunol; 2014 Jun 15; 59(2):136-41. PubMed ID: 24598312
    [Abstract] [Full Text] [Related]

  • 19. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
    Kang H, Qi Y, Wang H, Zheng X, Gao Y, Li N, Yang S, Xia X.
    Viruses; 2015 Mar 11; 7(3):1134-52. PubMed ID: 25768031
    [Abstract] [Full Text] [Related]

  • 20. Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic.
    McGettigan JP, Pomerantz RJ, Siler CA, McKenna PM, Foley HD, Dietzschold B, Schnell MJ.
    J Virol; 2003 Jan 11; 77(1):237-44. PubMed ID: 12477829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.